BDX Logo

Becton, Dickinson and Company (BDX) 

NYSE
Market Cap
$64.14B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
442 of 971
Rank in Industry
26 of 50

Largest Insider Buys in Sector

BDX Stock Price History Chart

BDX Stock Performance

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Insider Activity of Becton, Dickinson and Company

Over the last 12 months, insiders at Becton, Dickinson and Company have bought $0 and sold $2.39M worth of Becton, Dickinson and Company stock.

On average, over the past 5 years, insiders at Becton, Dickinson and Company have bought $0 and sold $12.79M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 30 shares for transaction amount of $7,439 was made by BURZIK CATHERINE M (director) on 2019‑04‑16.

List of Insider Buy and Sell Transactions, Becton, Dickinson and Company

2024-06-10SaleSVP,Controller&Chief Acct Off
300
0.0001%
$239.31$71,793-1.78%
2024-05-15SaleEVP and President EMEA
3,300
0.0011%
$236.73$781,224-0.86%
2024-05-13SaleEVP and President EMEA
3,300
0.0011%
$236.70$781,121-0.71%
2024-04-30SaleEVP & President Medical
1,715
0.0006%
$232.81$399,269+0.30%
2024-03-14SaleSVP,Controller&Chief Acct Off
282
<0.0001%
$238.29$67,198-0.75%
2023-12-11SaleEVP & President Medical
1,239
0.0004%
$232.46$288,018+1.64%
2023-11-28SaleEVP & President Interventional
2,156
0.0007%
$238.47$514,141-0.29%
2023-09-05SaleEVP & President Interventional
459
0.0002%
$274.48$125,986-12.73%
2023-08-28Saledirector
848
0.0003%
$281.66$238,848-15.36%
2023-08-11SaleEVP & President, Life Sciences
2,974
0.001%
$277.85$826,326-15.40%
2023-08-08SaleEVP & President Medical
1,300
0.0005%
$277.13$360,269-15.02%
2023-02-03SaleEVP & President Interventional
1,421
0.0005%
$248.60$353,261+3.07%
2022-08-15SaleChairman, CEO and President
9,500
0.0033%
$265.13$2.52M-5.02%
2022-08-15SaleEVP & President, Life Sciences
475
0.0002%
$265.00$125,875-5.02%
2022-08-09SaleExecutive Vice President
1,652
0.0006%
$260.00$429,520-0.74%
2022-08-09SaleEVP and General Counsel
7,295
0.0026%
$260.44$1.9M-0.74%
2022-06-07SaleVP Controller & Chief Acct Off
443
0.0002%
$260.00$115,180-3.38%
2022-05-06SaleEVP & President, Life Sciences
950
0.0003%
$256.00$243,200-3.17%
2022-02-25SaleEVP HR & CHRO
601
0.0002%
$271.90$163,412-4.92%
2022-02-08Saledirector
841
0.0003%
$271.70$228,500-5.95%

Insider Historical Profitability

6.05%
Goette RolandEVP and President EMEA
11308
0.0039%
$221.9004
Garrison Michael DavidEVP & President Medical
5381
0.0019%
$221.9003
Spoerel Thomas JSVP,Controller&Chief Acct Off
1976
0.0007%
$221.9007
FORLENZA VINCENT AChairman of the Board
208864
0.0723%
$221.90026
LUDWIG EDWARD JChairman
97188
0.0336%
$221.90039
RING TIMOTHY Mdirector
93688
0.0324%
$221.9003
CONSIDINE JOHN RVice Chairman
89650
0.031%
$221.9007
COHEN GARY MExecutive Vice President
71770
0.0248%
$221.90021
KOZY WILLIAM AExecutive Vice President
68823
0.0238%
$221.90023
HANSON ALFRED JOHNExecutive Vice President
40273
0.0139%
$221.9005
Polen Thomas E JrChairman, CEO and President
28878
0.01%
$221.90010
BECTON HENRY P JRdirector
23820
0.0082%
$221.90056
ORR JAMES Fdirector
23045
0.008%
$221.9003
SCOTT BERTRAM Ldirector
22416
0.0078%
$221.9002
SHERMAN JEFFREY SSr. VP and General Counsel
22094
0.0076%
$221.90017
Fraser Clairedirector
21608
0.0075%
$221.9007
Conroy AlexandreEVP of Integrated Supply Chain
21260
0.0074%
$221.9008
OVERLOCK WILARD J JRdirector
21091
0.0073%
$221.9022+1.24%
Mecklenburg Gary Adirector
20965
0.0073%
$221.9001
Lim James CExecutive Vice President
19768
0.0068%
$221.90010
DEGRAAN EDWARDdirector
18608
0.0064%
$221.9001
ANDERSON BASILdirector
17221
0.006%
$221.9001
SOMMER ALFREDdirector
16228
0.0056%
$221.9005
Boles Donna MSenior VP - Human Resources
14607
0.0051%
$221.9008
TOZZI WILLIAM AEVP Pres Interventional
13208
0.0046%
$221.90013
Tharby Linda MExecutive Vice President
11337
0.0039%
$221.9004
RIMEL REBECCA Wdirector
10618
0.0037%
$221.9006
Campion Simon DEVP and Segment President
10773
0.0037%
$221.9002
Kaltenbach PatrickEVP & Pres Life Sciences
10340
0.0036%
$221.9009
UGGLAS MARGERETHA AFdirector
10000
0.0035%
$221.9010+22.54%
BURZIK CATHERINE Mdirector
10007
0.0035%
$221.9031+5.53%
BEATY HARRY Ndirector
9204
0.0032%
$221.9001
DURACK DAVID TSenior Vice President
8382
0.0029%
$221.90022
Mas Ribo AlbertoEVP and Pres, Life Sciences
8381
0.0029%
$221.9006
Sichak StephenExecutive Vice President
7953
0.0028%
$221.90011
SHRADER PATRICIA BSenior Vice President
7915
0.0027%
$221.9004
Shabshab NabilExecutive Vice President
7811
0.0027%
$221.9005
Bruder Scott PSrVP; Chief Technology Officer
7626
0.0026%
$221.9001
Strahlman Ellen RSenior Vice President
6037
0.0021%
$221.9002
Khichi Samrat S.EVP and General Counsel
5928
0.0021%
$221.9003
Larson Betty DEVP HR & CHRO
5872
0.002%
$221.9003
Elkins David VExecutive VP and CFO
5513
0.0019%
$221.9001
DAGEVILLE JEAN MARCVP - Human Resources
4658
0.0016%
$221.9001
Hickey DavidEVP & President, Life Sciences
4199
0.0015%
$221.9004
Byrd RichardEVP & President Interventional
4120
0.0014%
$221.9003
Minehan Cathy E.director
3000
0.001%
$221.9020+2.05%
Borzi James WEVP & Chief Supply Chain Offcr
2775
0.001%
$221.9002
Hurwitz Jerome VExecutive Vice President
3027
0.001%
$221.9004
Melcher David Fdirector
2728
0.0009%
$221.9010+8.76%
Gallagher John EVP, Corp Finance and Treasurer
2099
0.0007%
$221.9005
Bodner Charles RSVP Corp Fin Chief Acct Office
2037
0.0007%
$221.9002

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$6.48B9.0626.18M+0.23%+$15.17M0.12
BlackRock$5.64B7.8922.81M+0.15%+$8.37M0.12
State Street$3.35B4.6813.53M+4.77%+$152.38M0.14
Morgan Stanley$2.65B3.7110.71M+0.01%+$339,254.020.2
T. Rowe Price$2.5B3.510.12M-2.56%-$65.71M0.31
T Rowe Price Investment Management Inc$1.86B2.67.5M+2.17%+$39.39M1.14
Geode Capital Management$1.49B2.096.03M+10.05%+$135.91M0.13
Massachusetts Financial Services Co Ma$1.19B1.674.82M+19.47%+$194.29M0.36
Wellington Management Company$1.18B1.654.75M-28.76%-$474.81M0.2
Ameriprise Financial$1.18B1.644.75M+12.36%+$129.32M0.33
JPMorgan Chase$1.13B1.584.56M-2.72%-$31.59M0.1
BNY Mellon$1.01B1.414.07M+4.42%+$42.56M0.19
Invesco$985.41M1.383.98M+5.98%+$55.58M0.2
Generation Investment Management Llp$791.93M1.113.2M+71.87%+$331.16M3.62
Franklin Templeton Investments$766.55M1.073.1M+0.87%+$6.64M0.23
ClearBridge Investments$716.46M12.9M-8.21%-$64.11M0.57
Northern Trust$659.19M0.922.66M-5.75%-$40.2M0.11
Mackenzie Financial Corp$641.38M0.92.59M-1.25%-$8.13M0.87
Mitsubishi UFJ Kokusai Asset Management$628.44M0.882.54M+4.35%+$26.19M0.84
Legal & General$598.21M0.842.42M-0.88%-$5.28M0.14
Longview Partners (Guernsey) LTD$574.44M0.82.32M+7.93%+$42.19M3.71
Vontobel Asset Management Inc$598.14M0.792.28M+10.59%+$57.29M3.31
Veritas Asset Management LLP$536.18M0.752.17M-0.75%-$4.07M3.89
First Eagle Investment Management$523.35M0.732.11M+8.24%+$39.86M1.19
Nordea Investment Management Ab$478.3M0.671.94M+277.29%+$351.53M0.57
Fiera Capital$478.06M0.671.93M-4.17%-$20.81M1.4
Teachers Pension Plan Board Ontario$475M0.661.92M+3.63%+$16.65M4.43
Amundi$428.8M0.641.84M-11.89%-$57.85M0.18
Bank of America$450.75M0.631.82M-67.06%-$917.62M0.04
American Century Investments$450.48M0.631.82M+14.93%+$58.5M0.28
Nuveen$444.24M0.621.79M+40.21%+$127.4M0.13
Wells Fargo$421.27M0.591.7M-54.41%-$502.69M0.11
CalPERS$418.64M0.591.69M-1.96%-$8.36M0.29
AllianceBernstein$402.76M0.561.63M+19.9%+$66.84M0.14
Charles Schwab$398.47M0.561.61M+2.49%+$9.69M0.09
Dimensional Fund Advisors$388.3M0.541.57M+4.08%+$15.21M0.1
Ubs Asset Management Americas Inc$387.71M0.541.57M-0.32%-$1.23M0.14
Diamond Hill Investment Group Inc$349.43M0.491.41M+22.85%+$65M1.43
Fidelity Investments$337.79M0.471.37M+1.57%+$5.21M0.02
Neuberger Berman$333.9M0.471.35M-24.02%-$105.56M0.28
Royal Bank of Canada$318.24M0.451.29M-18.53%-$72.4M0.08
Deutsche Bank$248.04M0.351M+7%+$16.23M0.11
Impax Asset Management Group$243.34M0.34985,782+7.16%+$16.26M0.93
Citadel Advisors LLC$238.08M0.33962,129-22.48%-$69.04M0.14
Jarislowsky Fraser Ltd$221.76M0.31896,176+3.63%+$7.77M1.27
Qube Research & Technologies$219.72M0.31887,944-26.14%-$77.75M0.26
Swiss National Bank$214.56M0.3867,102-4.42%-$9.92M0.14
Prudential Financial$194.5M0.27786,031+33.99%+$49.34M0.27
ProShares$189.19M0.27764,576+18.05%+$28.93M0.49
Cooke & Bieler, L.P.$179.42M0.25725,069+1.99%+$3.5M1.66
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.